NO20045469L - (S)-4-amino-5-klor-2-metoksy-N-[I-[ 1-(2-tetrahydrofurylkarbonyl)-4-piperidinylmetyl]-4-piperidinyl]benzamid, fremgangsmate for fremstilling, farmasoytiske sammensetninger inneholdende denne og intermediater derav - Google Patents
(S)-4-amino-5-klor-2-metoksy-N-[I-[ 1-(2-tetrahydrofurylkarbonyl)-4-piperidinylmetyl]-4-piperidinyl]benzamid, fremgangsmate for fremstilling, farmasoytiske sammensetninger inneholdende denne og intermediater deravInfo
- Publication number
- NO20045469L NO20045469L NO20045469A NO20045469A NO20045469L NO 20045469 L NO20045469 L NO 20045469L NO 20045469 A NO20045469 A NO 20045469A NO 20045469 A NO20045469 A NO 20045469A NO 20045469 L NO20045469 L NO 20045469L
- Authority
- NO
- Norway
- Prior art keywords
- tetrahydrofurylcarbonyl
- piperidinylmethyl
- benzamide
- piperidinyl
- chloro
- Prior art date
Links
- MMAHZLJRNLZQCI-NRFANRHFSA-N 4-amino-5-chloro-2-methoxy-n-[1-[[1-[(2s)-oxolane-2-carbonyl]piperidin-4-yl]methyl]piperidin-4-yl]benzamide Chemical compound COC1=CC(N)=C(Cl)C=C1C(=O)NC1CCN(CC2CCN(CC2)C(=O)[C@H]2OCCC2)CC1 MMAHZLJRNLZQCI-NRFANRHFSA-N 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000000543 intermediate Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 108091005482 5-HT4 receptors Proteins 0.000 abstract 1
- 101150049660 DRD2 gene Proteins 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 229960003638 dopamine Drugs 0.000 abstract 1
- 239000003623 enhancer Substances 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 230000005176 gastrointestinal motility Effects 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 239000002325 prokinetic agent Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002141262 | 2002-05-16 | ||
PCT/JP2003/006051 WO2003097638A1 (en) | 2002-05-16 | 2003-05-15 | (s)-4-amino-5-chloro-2-methoxy-n-[1-[1-(2-tetrahydrofurylcarbonyl)-4-piperidinylmethyl]-4-piperidinyl]benzamide, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20045469L true NO20045469L (no) | 2005-02-16 |
Family
ID=29267809
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20045469A NO20045469L (no) | 2002-05-16 | 2004-12-15 | (S)-4-amino-5-klor-2-metoksy-N-[I-[ 1-(2-tetrahydrofurylkarbonyl)-4-piperidinylmetyl]-4-piperidinyl]benzamid, fremgangsmate for fremstilling, farmasoytiske sammensetninger inneholdende denne og intermediater derav |
Country Status (26)
Country | Link |
---|---|
US (1) | US6696468B2 (cs) |
EP (1) | EP1362857B1 (cs) |
JP (1) | JP3643107B2 (cs) |
KR (1) | KR20040107520A (cs) |
CN (1) | CN1653063A (cs) |
AR (1) | AR040021A1 (cs) |
AT (1) | ATE273304T1 (cs) |
AU (1) | AU2003230245A1 (cs) |
BR (1) | BR0309933A (cs) |
CA (1) | CA2483368A1 (cs) |
CZ (1) | CZ20041084A3 (cs) |
DE (1) | DE60300021T2 (cs) |
DK (1) | DK1362857T3 (cs) |
ES (1) | ES2227500T3 (cs) |
HU (1) | HUP0501016A2 (cs) |
IL (1) | IL165012A0 (cs) |
MX (1) | MXPA04011332A (cs) |
NO (1) | NO20045469L (cs) |
PL (1) | PL372724A1 (cs) |
PT (1) | PT1362857E (cs) |
RU (1) | RU2004136853A (cs) |
SK (1) | SK50192004A3 (cs) |
TR (1) | TR200403020T2 (cs) |
TW (1) | TW200400186A (cs) |
WO (1) | WO2003097638A1 (cs) |
ZA (1) | ZA200409053B (cs) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9904377D0 (sv) * | 1999-12-01 | 1999-12-01 | Astra Pharma Prod | Pharmaceutical combinations |
SE0200844D0 (sv) | 2002-03-19 | 2002-03-19 | Astrazeneca Ab | Chemical compounds |
SE0200843D0 (sv) | 2002-03-19 | 2002-03-19 | Astrazeneca Ab | Chemical compounds |
SE0300957D0 (sv) | 2003-04-01 | 2003-04-01 | Astrazeneca Ab | Chemical compounds |
TW200533348A (en) * | 2004-02-18 | 2005-10-16 | Theravance Inc | Indazole-carboxamide compounds as 5-ht4 receptor agonists |
US7728006B2 (en) * | 2004-04-07 | 2010-06-01 | Theravance, Inc. | Quinolinone-carboxamide compounds as 5-HT4 receptor agonists |
US8309575B2 (en) | 2004-04-07 | 2012-11-13 | Theravance, Inc. | Quinolinone-carboxamide compounds as 5-HT4 receptor agonists |
TWI351282B (en) * | 2004-04-07 | 2011-11-01 | Theravance Inc | Quinolinone-carboxamide compounds as 5-ht4 recepto |
DE602005014566D1 (de) * | 2004-11-05 | 2009-07-02 | Theravance Inc | Chinolinon-carboxamid-verbindungen |
WO2006052640A1 (en) * | 2004-11-05 | 2006-05-18 | Theravance, Inc. | 5-ht4 receptor agonist compounds |
NZ555180A (en) * | 2004-12-22 | 2010-09-30 | Theravance Inc | Indazole-carboxamide compounds useful as 5-HT4 receptor agonists |
CN101163701A (zh) * | 2005-03-02 | 2008-04-16 | 施万制药 | 作为5-ht4受体激动剂的喹啉酮化合物 |
MY147756A (en) | 2005-05-25 | 2013-01-15 | Theravance Inc | Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists |
US7256294B2 (en) * | 2005-05-25 | 2007-08-14 | Theravance, Inc. | Crystalline form of a benzimidazole-carboxamide medicinal compound |
TW200722419A (en) * | 2005-05-27 | 2007-06-16 | Astrazeneca Ab | Chemical compounds |
WO2006126948A1 (en) * | 2005-05-27 | 2006-11-30 | Astrazeneca Ab | Piperidines for the treatment of chemokine mediated diseases |
ES2397418T3 (es) | 2005-07-21 | 2013-03-06 | Astrazeneca Ab | Derivados de piperidina |
GB0525068D0 (en) | 2005-12-08 | 2006-01-18 | Novartis Ag | Organic compounds |
TWI423967B (zh) * | 2008-02-21 | 2014-01-21 | Dainippon Sumitomo Pharma Co | 醯胺衍生物及含有其之醫藥組合物 |
US8349852B2 (en) | 2009-01-13 | 2013-01-08 | Novartis Ag | Quinazolinone derivatives useful as vanilloid antagonists |
EP2531510B1 (en) | 2010-02-01 | 2014-07-23 | Novartis AG | Pyrazolo[5,1b]oxazole derivatives as crf-1 receptor antagonists |
WO2011092293A2 (en) | 2010-02-01 | 2011-08-04 | Novartis Ag | Cyclohexyl amide derivatives as crf receptor antagonists |
WO2011095450A1 (en) | 2010-02-02 | 2011-08-11 | Novartis Ag | Cyclohexyl amide derivatives as crf receptor antagonists |
US8546416B2 (en) | 2011-05-27 | 2013-10-01 | Novartis Ag | 3-spirocyclic piperidine derivatives as ghrelin receptor agonists |
WO2013164790A1 (en) | 2012-05-03 | 2013-11-07 | Novartis Ag | L-malate salt of 2, 7 - diaza - spiro [4.5 ] dec- 7 - yle derivatives and crystalline forms thereof as ghrelin receptor agonists |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH111472A (ja) | 1996-04-30 | 1999-01-06 | Dainippon Pharmaceut Co Ltd | ベンズアミド誘導体及びそれを含有する医薬組成物 |
CN1118452C (zh) | 1998-04-28 | 2003-08-20 | 大日本制药株式会社 | 1-[(1-取代-4-哌啶基)甲基]-4-哌啶衍生物、其生产方法、含有该化合物的药物组合物和这些化合物的中间体 |
JP2000080081A (ja) | 1998-06-24 | 2000-03-21 | Dainippon Pharmaceut Co Ltd | 1―〔(1―置換―4―ピペリジニル)メチル〕―4―ピペリジン誘導体及びそれを含有する医薬組成物 |
JP2001122784A (ja) | 1999-10-27 | 2001-05-08 | Dainippon Pharmaceut Co Ltd | 1−[(1−置換−4−ピペリジニル)メチル]−4−ピペリジン誘導体からなる医薬 |
-
2002
- 2002-12-18 US US10/321,615 patent/US6696468B2/en not_active Expired - Fee Related
-
2003
- 2003-01-03 PT PT03250050T patent/PT1362857E/pt unknown
- 2003-01-03 ES ES03250050T patent/ES2227500T3/es not_active Expired - Lifetime
- 2003-01-03 DE DE60300021T patent/DE60300021T2/de not_active Expired - Fee Related
- 2003-01-03 EP EP03250050A patent/EP1362857B1/en not_active Expired - Lifetime
- 2003-01-03 DK DK03250050T patent/DK1362857T3/da active
- 2003-01-03 AT AT03250050T patent/ATE273304T1/de not_active IP Right Cessation
- 2003-05-08 TW TW092112525A patent/TW200400186A/zh unknown
- 2003-05-15 RU RU2004136853/04A patent/RU2004136853A/ru not_active Application Discontinuation
- 2003-05-15 TR TR2004/03020T patent/TR200403020T2/xx unknown
- 2003-05-15 SK SK5019-2004A patent/SK50192004A3/sk unknown
- 2003-05-15 BR BR0309933-4A patent/BR0309933A/pt not_active Application Discontinuation
- 2003-05-15 CN CNA03811089XA patent/CN1653063A/zh active Pending
- 2003-05-15 IL IL16501203A patent/IL165012A0/xx unknown
- 2003-05-15 CZ CZ20041084A patent/CZ20041084A3/cs unknown
- 2003-05-15 MX MXPA04011332A patent/MXPA04011332A/es unknown
- 2003-05-15 AU AU2003230245A patent/AU2003230245A1/en not_active Abandoned
- 2003-05-15 CA CA002483368A patent/CA2483368A1/en not_active Abandoned
- 2003-05-15 HU HU0501016A patent/HUP0501016A2/hu unknown
- 2003-05-15 KR KR10-2004-7018158A patent/KR20040107520A/ko not_active Withdrawn
- 2003-05-15 PL PL03372724A patent/PL372724A1/xx not_active Application Discontinuation
- 2003-05-15 AR ARP030101702A patent/AR040021A1/es unknown
- 2003-05-15 JP JP2003137413A patent/JP3643107B2/ja not_active Expired - Fee Related
- 2003-05-15 WO PCT/JP2003/006051 patent/WO2003097638A1/en not_active Application Discontinuation
-
2004
- 2004-11-09 ZA ZA200409035A patent/ZA200409053B/en unknown
- 2004-12-15 NO NO20045469A patent/NO20045469L/no unknown
Also Published As
Publication number | Publication date |
---|---|
DE60300021D1 (de) | 2004-09-16 |
TW200400186A (en) | 2004-01-01 |
BR0309933A (pt) | 2005-02-09 |
DK1362857T3 (da) | 2004-12-20 |
ES2227500T3 (es) | 2005-04-01 |
SK50192004A3 (sk) | 2005-04-01 |
MXPA04011332A (es) | 2005-02-14 |
US6696468B2 (en) | 2004-02-24 |
HK1060118A1 (en) | 2004-07-30 |
RU2004136853A (ru) | 2005-06-27 |
CN1653063A (zh) | 2005-08-10 |
PT1362857E (pt) | 2004-11-30 |
DE60300021T2 (de) | 2005-09-08 |
EP1362857B1 (en) | 2004-08-11 |
ZA200409053B (en) | 2005-07-12 |
HUP0501016A2 (en) | 2006-02-28 |
IL165012A0 (en) | 2005-12-18 |
EP1362857A1 (en) | 2003-11-19 |
TR200403020T2 (tr) | 2005-05-23 |
AU2003230245A1 (en) | 2003-12-02 |
WO2003097638A1 (en) | 2003-11-27 |
JP3643107B2 (ja) | 2005-04-27 |
CZ20041084A3 (cs) | 2005-02-16 |
KR20040107520A (ko) | 2004-12-20 |
CA2483368A1 (en) | 2003-11-27 |
JP2004043453A (ja) | 2004-02-12 |
AR040021A1 (es) | 2005-03-09 |
ATE273304T1 (de) | 2004-08-15 |
PL372724A1 (en) | 2005-07-25 |
US20030216433A1 (en) | 2003-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20045469L (no) | (S)-4-amino-5-klor-2-metoksy-N-[I-[ 1-(2-tetrahydrofurylkarbonyl)-4-piperidinylmetyl]-4-piperidinyl]benzamid, fremgangsmate for fremstilling, farmasoytiske sammensetninger inneholdende denne og intermediater derav | |
NO20045120L (no) | Triazolderivater som takykininreseptorantagonister | |
NO20061519L (no) | Benzimiflazolonforbindelser som har 5HT4-reseptorantagonistisk aktivitet | |
NO20055568L (no) | Substituerte 1,4-diazepiner og anvendelser derav | |
WO2003064387A3 (en) | Substituted indoles as alpha-1 agonists | |
DE602006017694D1 (de) | C-verknüpfte zyklische antagonisten des p2y1-rezeptors mit eignung bei der behandlung thrombotischer leiden | |
NO20063748L (no) | Kinolinderivater og anvendelse derav som mykobakterielle inhibitorer | |
NO20051036L (no) | 3,4-disubstituerte syklobuten-1,2-dioner som CXC-kjemokinreseptorligander | |
EA200301306A1 (ru) | Производные 1-фенилсульфонил-1,3-дигидро-2h-индол-2-она, их получение и их терапевтическое применение | |
CA2388142A1 (en) | Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase | |
WO2003062248A3 (en) | N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as edg receptor agonists | |
MXPA03011638A (es) | Nuevos derivados de 4-piperazinil indol con afinidad por el receptor 5-ht6. | |
NO20051871L (no) | Opioidreseptorantagonister | |
SE0302760D0 (sv) | New compounds | |
NO20032861L (no) | Heteroarylurea nevropeptid Y Y5-reseptorantagonister | |
WO2004048330A8 (en) | N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them | |
WO2006113552A8 (en) | Cyanoarylamines | |
NO20082330L (no) | Nye krystallinske polymorfe former av lerkanidipinhydroklorid og fremgangsmate for fremstilling derav | |
MXPA05013474A (es) | Derivados de quinolilamida como antagonistas de ccr-5. | |
EA200601194A1 (ru) | Новые производные бензофурана, используемые для профилактики или лечения нарушений, связанных с 5-ht-рецептором | |
NO20071372L (no) | Nye polymorfer av azabisykloheksan | |
WO2005060959A8 (en) | Pyrazole derivatives and use thereof as orexin receptor antagonists | |
ATE308522T1 (de) | Opioidrezeptorantagonisten | |
NO20052676L (no) | Polymorfer av bicifadin-saltsyre | |
NO20060191L (no) | 1-(alkylaminoalkyl-pyrolidin-/piperidinyl)2,2-difenylacetamidderivater som muskarinreceptoragonister |